1 Sep/10
By Dan Bobear (@dbobear) Now that AstraZeneca's experimental blood thinner Brilinta has been given the green light by an advisory committee of the U.S. Food and Drug Administration, they need to...
Posted in Digital Health
|
Tagged AstraZeneca, audience, Blogs, branding, Facebook, image, interaction, location-based, marketing, Patients, physicians, social media, Twitter, YouTube
|